A Study for Detection of Axillary and Non-Axillary Sentinel Lymph Nodes in Operable Breast Carcinoma, using Patent Blue Dye

Abstract

A controlled randomized trial is carried out on thirty female patients suffering from operable breast cancer stage (I & II) patients were divided into two groups: Group I: Fifteen Patients were injected by patent blue dye at the peritumoral region. Group II: Fifteen Patients were injected by patent blue dye at the subareolar region. All patients were subjected to:

-Full history taking.

-Meticulous clinical examination, including both axillae for any clinically palpable lymph nodes. -Routine laboratory investigations.

-Plain X-ray chest.

-Abdominal ultrasonongraphy.

Intraoperative injection of five ml of patent blue dye via a 25-gauge needle peritumoral in group I and subareolar in group !!.Manual compression of the breast with gentle massage was done for five minutes. A modified radical mastectomy was performed upon all patients with total axillary lymph node dissection.